JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, M.
Right arrow Articles by Carr, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, M.
Right arrow Articles by Carr, D. J.

Morphine suppresses the alloantigen-driven CTL response in a dose- dependent and naltrexone reversible manner

M Scott and DJ Carr

Department of Microbiology and Immunology, Louisiana State University Neuroscience, New Orleans, USA.

Previous studies have shown morphine (50.0 mg/kg, s.c.) suppresses cytotoxic T lymphocyte (CTL) activity in alloimmunized mice. The present study was undertaken to assess the dose-dependent nature of the suppressive effect of subchronic morphine exposure on CTL activity in vivo. In alloimmunized ICR mice, morphine (10.0-100.0 mg/kg, s.c.) administered daily for 5 days significantly suppressed CTL activity ( > 50%) in a dose-dependent and naltrexone (10.0 mg/kg, s.c.)-reversible fashion. The morphine-treated mice showed tolerance to the drug after daily exposure over 5 days as determined by measuring tail flick latency during thermal application. CD4(+)- and CD8(+)-depletion studies showed that effector cells were predominately CD8+ and mediated cytolysis through a Ca(++)-dependent pathway. Splenocytes obtained from the morphine (56.0-100.0 mg/kg)-treated, alloimmunized mice produced significantly less (30-40%) interferon-gamma but not interleukin-2 or interleukin-10 after antigen stimulation but not concanavalin A stimulation. Furthermore, this effect was dose- and time-dependent. In addition, there was a modest decrease (10%) in the interferon-gamma transcript level from the morphine (56.0-100.0 mg/kg)-treated, alloimmunized mice compared with vehicle-treated, alloimmunized mice as determined by quantitative reverse transcription-polymerase chain reaction. However, there were no differences in the perforin transcript levels between morphine- and vehicle-treated mice. Collectively, these results suggest that subchronic morphine exposure suppresses CTL activity in tolerized, alloimmunized mice through a pathway that may peripherally involve interferon-gamma production.

Volume 278, Issue 2, pp. 980-988, 08/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 CirculationHome page
M.-W. Hwang, A. Matsumori, Y. Furukawa, K. Ono, M. Okada, A. Iwasaki, M. Hara, and S. Sasayama
FTY720, a New Immunosuppressant, Promotes Long-Term Graft Survival and Inhibits the Progression of Graft Coronary Artery Disease in a Murine Model of Cardiac Transplantation
Circulation, September 21, 1999; 100(12): 1322 - 1329.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. E. Nowak, R. Gomez-Flores, S. N. Calderon, K. C. Rice, and R. J. Weber
Rat Natural Killer Cell, T Cell and Macrophage Functions after Intracerebroventricular Injection of SNC 80
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 931 - 937.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.